Blood Coagulation Testing Market Research Report - Forecast till 2027

Blood Coagulation Testing Market Information: By Product (Clinical Laboratory, Automated), Application (Bleeding Disorders, Von Willebrand Disease), Test Type (Testing Kits), and End Users (Academic Institutions, Hospitals) - Forecast till 2027

ID: MRFR/LS/0464-HCR | February 2021 | Region: Global | 115 pages

Blood Coagulation Testing Market Overview 


The blood coagulation testing market demand rate is expected to increase by 6.5% by 2023. Coagulation testing is a process analysis of the time duration of blood clotting. This process is crucial in the process of excessive bleeding conditions. Coagulation can occur due to plenty of reasons. Also, Liver disease and haemophilia are some of the diseases that cause this condition. The physical properties of the blood change due to the process. Soluble plasma is changed into a solid gel. The blood coagulation testing market is witnessing massive demand from many regions.


The Asia Pacific and North America are regions with high growth opportunities for the blood coagulation testing market. The blood disorders, rising cardiovascular problems are leading to high growth for the blood coagulation testing market. Through prothrombic tests have tremendous demand in many regions. The conditions such as extreme thrombosis will lead to the immense demand for blood coagulation.


The use of this product is high in laboratories and hospitals. Today, with online and digital medication the market is expanding more. The use of coagulation sensors is making the blood coagulation testing market scenarios more favourable. In the upcoming year, the usage of these coagulants will be higher in many health infrastructures. The new technological developments in the blood coagulation testing market are expected to attract more end-users. All this will lead to a spectacular market value of blood coagulation testing. 


Covid analysis 


The outbreak of covid 19 is causing unprecedented changes in the global markets. It is causing much pressure to industries. The economic crisis is leading to revenue losses in various markets. Further, health emergency is affecting the daily operations of the business. The supply chain disruptions are massive for many companies. The governmental restriction is causing delays to meet the customer demand. 


Blood coagulation is facing a few difficulties during this period. Most of these tests happen in hospitals and laboratories. However, the health sector is occupied in covid patient care. Also, covid treatment and vaccination are disrupting other treatments. In 2020 several patients were allowed to hospitals for emergency conditions. Treatment for thrombosis and cardiovascular problems is delayed in many hospitals. As per blood coagulation testing market analysis the growth of the blood coagulation testing market is more in this period. Post covid 19, the blood coagulation testing will have exceptional demand. Also, the production and supply activities are expected to be massive. 


Market dynamics 



  • Crucial market drivers 


The prevalence of cardiovascular and blood disorders is a crucial driver for the blood coagulation testing market. In recent times, the rate of blood disorders is surging. Cardiovascular diseases and their symptoms require blood coagulation testing’s. Also, blood disorders require this testing process for further treatment. Furthermore, the need for effective treatment for haemophilia, liver disease and thrombophilia is tremendous. These conditions can lead to excessive bleeding. All these conditions require blood coagulation testing to make the blood plasma into solid gels.


The demand for blood coagulation for these treatments will lead to remarkable demand in the blood coagulation testing market. Further, government investments to enhance health infrastructure is a crucial driver. The governmental initiative is exceptional support to the health industry. Through these investments installation of new medical devices is possible.


 The blood coagulation testing market has higher adoption due to a rise in investment. Adoption of these testing technologies leads to effective and efficient treatment for blood disorders. The expansion of health care facilities is bringing favourable changes in the blood coagulation testing market. With a high number of clinic and hospitals, the treatment for these problems is quick. Also, with more hospitals, the adoption of blood coagulation testing rises. 



  • Market growth opportunities 


The technological developments in the blood coagulation testing market will lead to high growth opportunities. There are plenty of innovations in blood testing techniques. The advanced technologies will create more demand in the upcoming years. These enough end technologies are photo detection, fluorescent microscopy, electrochemical sensing and micro fluids.


These technologies make the blood testing process cost-effective and efficient. All these factors will lead to robust growth opportunities in the blood coagulation testing market. Furthermore, smartphones enabled blood coagulation will lead to more growth possibilities. It is a self-testing technology that can track patient’s conditions under anticoagulant therapy.


This facility helps to test patients at home. Visiting hospitals for a very checkup is reduced by this technology. The prothrombic and thromboplastin procedure is tracked through the technology. These results are highly reliable and accurate. This innovation in the blood coagulation testing market can lead to enormous supply rates. Due to these growth possibilities, the blood coagulation revenue rates will be higher. 



  • The market restraints 


The stringent regulatory process in the blood coagulation testing market is a restraining factor. To carry out blood coagulation testing there are plenty of regulations. This process requires expert’s supervision or it can be a life threading procedure. Due to this, the regulatory process for the process is high.


Only certain levels of medication are used to change the blood from soluble state into the gel. The medical norms and governmental norms during this procedure create disruptions. Delay to get approval and high time consumption are some factors affecting the growth. It retains of the blood coagulation testing market can affect the demand rate. 



  • The market challenges 


The high cost incurred in blood coagulation testing is a significant challenge. Blood coagulation is the advanced producer. It is a procedure that requires various checkups and steps. The entire blood coagulation process is expensive. Only some part of the population can afford ties treatment. This can lead to less demand for the test in the forecast period. Further, the poor reimbursements in many regions for blood coagulation testing can cause hindrance.


North America is a region that offers various reimbursements for medical procedures. However, developing regions such as the Asia Pacific market has poor reimbursements. The lack of these policies makes it tough to afford the treatment. No assistance from the government through reimbursements can affect the overall growth of the blood coagulation testing market. 



  • Cumulative growth analysis 


The blood coagulation testing market trends remain steady in the forecast period. The adoption of blood coagulation testing is massive in several hospitals and health facilities. The prevalence of blood disorders and cardiovascular conditions is leading to high adoption. The crucial drivers of the blood coagulation testing market such as the governmental investments for the health industry are leading to gig her developments.


Further, the expansion of the health industry leads to more adoption of medical devices. All these factors ultimately impact his blood coagulation testing market positively. However, the high cost and stringent regulatory norms are drawbacks in the market. The growth opportunities that are technological advancements will lead to exceptional developments. 



  • Value chain analysis 


The North American regions dominate with blood coagulation testing market share. The healthcare scenarios are favourable for blood coagulation testing market growth. The top key players in the region bring innovation and cost-effectiveness to the audience. 


The prevalence of deep vein thrombosis is driving demand in North America. Canada and US Rae regions have higher investments in the market. Furthermore, advanced medical devices, health centres and experts create more developments. North America will be the early adopter for new blood coagulation techniques. Also, exceptional reimbursements for blood testing will lead to higher growth. 


Segment overview 


By product 



  • Automated 

  • Clinical laboratory 


By application 



  • Bleeding disorders 

  • Von wile brand disease 


By end-users 



  • Clinics 

  • Laboratories 

  • Hospitals 

  • Academic institutions 


By region 



  • Asia pacific 

  • Europe 

  • South America 

  • North America 

  • The Middle East and Africa 


Competitive landscape 


The competition in the blood coagulation market is expected to grow in the forecast period. There will be competition in adopting the new techniques of blood coagulation technique. Also, price competition is expected to be high in the upcoming years. Technological advancements and innovations are the key strategies in the market. Also, market accusations, expansion and internships will happen in upcoming years. 


Regional analysis 


The crucial regions in the blood coagulation market are Asia Pacific, Europe and North America. North America will continue to lead the market with higher demand. Further, high investments in the region can lead to product launches. Also, the prevalence of the chronic disease will lead to higher demand North America is a region that will record the highest revenue rates.


Asia pacific will have a higher demand for blood coagulation testing in the forecast period. Road accidents are the deriving factors for these tests. Also, Europe is another market with high demand due to chronic heart problems. The death rate due to heart problems is amounting to 3.9 billion in Europe. It is leading to plenty of medical advancements in the region. Also, the Middle East has high growth scope for the blood coagulation market. 


The key players in the blood coagulation testing market are 



  • Danaher

  • Abbott Laboratories 

  • Bios stem S.A.

  • Helena Laboratories 

  • Siemens

  • Hoffmann-La Roche

  • laboratory Corporation of America Holding

  • Sienco, Inc

  • A&T Corporation


Recent developments 



  1. The key players in the Middle East are opening new facilities for blood coagulation testing. Especially, Dubai is a central region for such developments.  



  1. The key players in North America are developing the blood cog laser analyzer that makes patient condition tracking effortless. 


Market overview



  1. Market overview highlights 

  2. Analysis based upon COVID 19

  3. Explanation upon the Market Dynamics

  4. Value chain analysis

  5. Market segmentation overview

  6. The regional analysis

  7. Competitive landscape analysis

  8. Recent Developments



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   6.5 % (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product, Application, Test Type, and End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   F. Hoffmann-La Roche Ltd. (Europe), Alere Inc. (U.S.), Siemens Healthcare Private Limited (Europe), Accriva Diagnostics (U.S.A.), CoaguSense, Inc. (U.S.), HomoSonics LLC. (U.S.), iLine Microsystems. (Europe), Instrumentation Laboratory (U.S.), Sienco, Inc. (U.S.), SenGenix Inc. (U.S.), Bio/Data Corporation (U.S.)
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Advancing Technology in blood coagulation testing
  • Increasing prevalence of liver disease, thrombophilia, and hemophilia


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    The Blood Coagulation Testing Market is projected Growth of CAGR of 6.5 % during the forecast period 2017-2023.

    The America is growing at the highest CAGR over 2017- 2023

    The key players in Global Blood Coagulation Testing Market are F. Hoffmann-La Roche Ltd. (Europe), Alere Inc. (U.S.), Siemens Healthcare Private Limited (Europe), Accriva Diagnostics (U.S.A.), CoaguSense, Inc. (U.S.), HomoSonics LLC. (U.S.), iLine Microsystems. (Europe), Instrumentation Laboratory (U.S.), Sienco, Inc. (U.S.), SenGenix Inc. (U.S.), Bio/Data Corporation (U.S.)

    The major players for the blood coagulation testing market are F. Hoffmann-La Roche Ltd. (Europe), Alere Inc. (U.S.), Siemens Healthcare Private Limited (Europe), Accriva Diagnostics (U.S.A.), CoaguSense, Inc. (U.S.), HomoSonics LLC. (U.S.), iLine Microsystems. (Europe), Instrumentation Laboratory (U.S.), Sienco, Inc. (U.S.), SenGenix Inc. (U.S.), Bio/Data Corporation (U.S.)

    Table of Content

    1. Report Prologue

    2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary research

    3.4 Market Size Estimation

    4. Market Dynamics

    4.1 Drivers

    4.2 Restrains

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    5. Market Factor Analysis

    5.1 Porters Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    6. Global Blood Coagulation Testing Market, by Product

    6.1 Introduction

    6.2 Clinical Laboratory

    6.2.1 Market Estimates & Forecast, 2020-2027

    6.3 Automated

    6.3.1 Market Estimates & Forecast, 2020-2027

    6.4 Semi-Automated Testing

    6.4.1 Market Estimates & Forecast, 2020-2027

    7. Global Blood Coagulation Testing Market, by Application

    7.1 Introduction

    7.2 Bleeding Disorders

    7.2.1 Market Estimates & Forecast, 2020-2027

    7.3 Acquired Bleeding Disorders

    7.3.1 Market Estimates & Forecast, 2020-2027

    7.4 Von Willebrand Disease

    7.4.1 Market Estimates & Forecast, 2020-2027

    7.5 Hemophilia

    7.5.1 Market Estimates & Forecast, 2020-2027

    8. Global Blood Coagulation Testing Market, by Test Type

    8.1 Introduction

    8.2 Testing Kits

    8.2.1 Market Estimates & Forecast, 2020-2027

    8.3 Others

    8.3.1 Market Estimates & Forecast, 2020-2027

    9. Global Blood Coagulation Testing Market, by End User

    9.1 Introduction

    9.2 Academic Institutions

    9.2.1 Market Estimates & Forecast, 2020-2027

    9.3 Hospitals

    9.3.1 Market Estimates & Forecast, 2020-2027

    9.4 Diagnostic Laboratories

    9.4.1 Market Estimates & Forecast, 2020-2027

    10. Global Blood Coagulation Testing Market, by Region

    10.1 Introduction

    10.2 Americas

    10.2.1 North America

    10.2.1.1 U.S.

    10.2.1.2 Canada

    10.2.2 South America

    10.3 Europe

    10.3.1 Western Europe

    10.3.1.1 Germany

    10.3.1.2 France

    10.3.1.3 U.K.

    10.3.1.4 Italy

    10.3.1.5 Spain

    10.3.1.6 Rest of Western Europe

    10.3.2 Eastern Europe

    10.4 Asia Pacific

    10.4.1 Japan

    10.4.2 China

    10.4.3 India

    10.4.4 Australia

    10.4.5 Republic of Korea

    10.4.6 Rest of Asia Pacific

    10.5 The Middle East & Africa

    10.5.1 United Arab Emirates

    10.5.2 Saudi Arabia

    10.5.3 Oman

    10.5.4 Kuwait

    10.5.5 Qatar

    10.5.6 Rest of the Middle East & Africa

    11 Company Landscape

    11.1 Introduction

    11.2 Market Share Analysis

    11.3 Key Development & Strategies

    11.3.1 Key Developments

    12 Company Profiles

    12.1 F. Hoffmann-La Roche Ltd

    12.1.1 Company Overview

    12.1.2 Product Overview

    12.1.3 Financials

    12.1.4 SWOT Analysis

    12.2 Alere Inc.

    12.2.1 Company Overview

    12.2.2 Product Overview

    12.2.3 Financial Overview

    12.2.4 Key Developments

    12.2.5 SWOT Analysis

    12.3 Siemens Healthcare

    12.3.1 Company Overview

    12.3.2 Product Overview

    12.3.3 Financial Overview

    12.3.4 Key Development

    12.3.5 SWOT Analysis

    12.4 Accriva Diagnostics

    12.4.1 Company Overview

    12.4.2 Product/Business Segment Overview

    12.4.3 Financial Overview

    12.4.4 Key Development

    12.4.5 SWOT Analysis

    12.5 CoaguSense, Inc.

    12.5.1 Company Overview

    12.5.2 Product Overview

    12.5.3 Financial overview

    12.5.4 Key Developments

    12.6 HomoSonics LLC.

    12.6.1 Company Overview

    12.6.2 Product Overview

    12.6.3 Financial Overview

    12.6.4 Key Developments

    12.7 SenGenix Inc.

    12.7.1 Overview

    12.7.2 Product Overview

    12.7.3 Financials

    12.7.4 Key Developments

    12.7.5 SWOT Analysis

    12.8 Others

    13 MRFR Conclusion

    13.1 Key Findings

    13.1.1 From CEO’s View Point

    13.1.2 Unmet Needs of the Market

    13.2 Key Companies to Watch

    13.3 Prediction of Pharmaceutical Industry

    14 Appendix

    LIST OF TABLES

    Table 1 Blood coagulation testing Industry Synopsis, 2020-2027

    Table 2 Global Blood coagulation testing Market Estimates and Forecast, 2020-2027, (USD Million)

    Table 3 Global Blood coagulation testing Market by Region, 2020-2027, (USD Million)

    Table 4 Global Blood coagulation testing Market by Products, 2020-2027, (USD Million)

    Table 5 Global Blood coagulation testing Market by Application, 2020-2027, (USD Million)

    Table 6 Global Blood coagulation testing Market by Test Type, 2020-2027, (USD Million)

    Table 7 Global Blood coagulation testing Market by End Users, 2020-2027, (USD Million)

    Table 8 North America Blood coagulation testing Market by Products, 2020-2027, (USD Million)

    Table 9 North America Blood coagulation testing Market by Application, 2020-2027, (USD Million)

    Table 10 North America Blood coagulation testing Market by Test Type, 2020-2027, (USD Million)

    Table 11 North America Blood coagulation testing Market by End Users, 2020-2027, (USD Million)

    Table 12 US Blood coagulation testing Market by Products, 2020-2027, (USD Million)

    Table 13 US Blood coagulation testing Market by Application, 2020-2027, (USD Million)

    Table 14 US Blood coagulation testing Market by Test Type, 2020-2027, (USD Million)

    Table 15 US Blood coagulation testing Market by End Users, 2020-2027, (USD Million)

    Table 16 Canada Blood coagulation testing Market by Products, 2020-2027, (USD Million)

    Table 17 Canada Blood coagulation testing Market by Application, 2020-2027, (USD Million)

    Table 18 Canada Blood coagulation testing Market by Test Type, 2020-2027, (USD Million)

    Table 19 Canada Blood coagulation testing Market by End Users, 2020-2027, (USD Million)

    Table 20 South America Blood coagulation testing Market by Products, 2020-2027, (USD Million)

    Table 21 South America Blood coagulation testing Market by Application, 2020-2027, (USD Million)

    Table 22 South America Blood coagulation testing Market by Test Type, 2020-2027, (USD Million)

    Table 23 South America Blood coagulation testing Market by End Users, 2020-2027, (USD Million)

    Table 24 Europe Blood coagulation testing Market by Products, 2020-2027, (USD Million)

    Table 25 Europe Blood coagulation testing Market by Application, 2020-2027, (USD Million)

    Table 26 Europe Blood coagulation testing Market by Test Type, 2020-2027, (USD Million)

    Table 27 Europe Blood coagulation testing Market by End Users, 2020-2027, (USD Million)

    Table 28 Western Europe Blood coagulation testing Market by Products, 2020-2027, (USD Million)

    Table 29 Western Europe Blood coagulation testing Market by Application, 2020-2027, (USD Million)

    Table 30 Western Europe Blood coagulation testing Market by Test Type, 2020-2027, (USD Million)

    Table 31 Western Europe Blood coagulation testing Market by End Users, 2020-2027, (USD Million)

    Table 32 Eastern Europe Blood coagulation testing Market by Products, 2020-2027, (USD Million)

    Table 33 Eastern Europe Blood coagulation testing Market by Application, 2020-2027, (USD Million)

    Table 34 Eastern Europe Blood coagulation testing Market by Test Type, 2020-2027, (USD Million)

    Table 35 Eastern Europe Blood coagulation testing Market by End Users, 2020-2027, (USD Million)

    Table 36 Asia Pacific Blood coagulation testing Market by Products, 2020-2027, (USD Million)

    Table 37 Asia Pacific Blood coagulation testing Market by Application, 2020-2027, (USD Million)

    Table 38 Asia Pacific Blood coagulation testing Market by Test Type, 2020-2027, (USD Million)

    Table 39 Asia Pacific Blood coagulation testing Market by End Users, 2020-2027, (USD Million)

    Table 40 Middle East & Africa Blood coagulation testing Market by Products, 2020-2027, (USD Million)

    Table 41 Middle East & Africa Blood coagulation testing Market by Application, 2020-2027, (USD Million)

    Table 42 Middle East & Africa Blood coagulation testing Market by Test Type, 2020-2027, (USD Million)

    Table 43 Middle East & Africa Blood coagulation testing Market by End Users, 2020-2027, (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Blood coagulation testing Market

    Figure 3 Segmentation Market Dynamics for Blood coagulation testing Market

    Figure 4 Global Blood coagulation testing Market Share, by Product 2020

    Figure 5 Global Blood coagulation testing Market Share, by Application 2020

    Figure 6 Global Blood coagulation testing Market Share, by Test Type 2020

    Figure 7 Global Blood coagulation testing Market Share, by End Users, 2020

    Figure 8 Global Blood coagulation testing Market Share, by Region, 2020

    Figure 9 Americas Blood coagulation testing Market Share, by Country, 2020

    Figure 10 Europe Blood coagulation testing Market Share, by Country, 2020

    Figure 11 Asia Pacific Blood coagulation testing Market Share, by Country, 2020

    Figure 12 Middle East & Africa Blood coagulation testing Market Share, by Country, 2020

    Figure 13 Global Blood coagulation testing Market: Company Share Analysis, 2020 (%)

    Figure 14 F. Hoffmann-La Roche Ltd: Key Financials

    Figure 15 F. Hoffmann-La Roche Ltd: Segmental Revenue

    Figure 16 F. Hoffmann-La Roche Ltd: Geographical Revenue

    Figure 17 Alere Inc.: Key Financials

    Figure 18 Alere Inc.: Segmental Revenue

    Figure 19 Alere Inc.: Geographical Revenue

    Figure 20 Siemens Healthcare: Key Financials

    Figure 21 Siemens Healthcare: Segmental Revenue

    Figure 22 Siemens Healthcare: Geographical Revenue

    Figure 23 Accriva Diagnostics: Key Financials

    Figure 24 Accriva Diagnostics: Segmental Revenue

    Figure 25 Accriva Diagnostics: Geographical Revenue

    Figure 26 CoaguSense, Inc.: Key Financials

    Figure 27 CoaguSense, Inc.: Segmental Revenue

    Figure 28 CoaguSense, Inc.: Geographical Revenue

    Figure 29 HomoSonics LLC: Key Financials

    Figure 30 HomoSonics LLC: Segmental Revenue

    Figure 31 HomoSonics LLC: Geographical Revenue

    Figure 32 SenGenix Inc.: Key Financials

    Figure 33 SenGenix Inc.: Segmental Revenue

    Figure 34 SenGenix Inc.: Geographical Revenue